ECAT Stock Analysis: BlackRock ESG Capital | NYSE

Asset Management | NYSE, USA | Market Cap: 1.447m USD | 12M Return: 6.9% | US09262F1003 | Charts, Fundamentals & Technical Analysis

Total Rating 35
Safety 24
Buy Signal -0.39
Asset Management
Industry Rotation: -4.9
Market Cap: 1.45B
Avg Turnover: 7.70M
Risk 3d forecast
Volatility19.6%
VaR 5th Pctl3.68%
VaR vs Median14.2%
Reward TTM
Sharpe Ratio0.24
Rel. Str. IBD46.1
Rel. Str. Peer Group51.5
Character TTM
Beta0.917
Beta Downside0.937
Hurst Exponent0.475
Drawdowns 3y
Max DD15.79%
CAGR/Max DD1.22
CAGR/Mean DD9.01
EPS (Earnings per Share) EPS (Earnings per Share) of ECAT over the last years for every Quarter: "2021-12": null, "2022-06": -3.24, "2022-12": 0.26, "2023-12": null, "2024-12": null, "2025-12": null,
Qual. Beats: 0
Revenue Revenue of ECAT over the last years for every Quarter: 2021-12: 84.349807, 2022-06: null, 2022-12: -311.169313, 2023-12: 297.441776, 2024-12: 244.601144, 2025-12: 216.227545,
Rev. CAGR: -14.74%
Rev. Trend: -99.2%
Qual. Beats: 0

Warnings

No concerns identified

Tailwinds

No distinct edge detected

Seasonality 5 years of data

Jan +1.1% 42
Feb -0.7% 21
Mar -2.5% 20
Apr -1.8% 20
May +4.4% 26
Jun +1.0% 23
Jul +0.1% 0
Aug -0.1% 18
Sep -3.2% 23
Oct -1.8% 24
Nov +4.1% 22
Dec -2.6% 23

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: ECAT BlackRock ESG Capital
Headlines to Watch Out For
Piotroski VR-10 (Strict) 6.5
Net Income: 213.4m TTM > 0 and > 6% of Revenue
FCF/TA: 0.20 > 0.02 and ΔFCF/TA 0.91 > 1.0
NWC/Revenue: -72.03% < 20% (prev -54.30%; Δ -17.73% < -1%)
CFO/TA 0.20 > 3% & CFO 344.6m > Net Income 213.4m
Net Debt (-5.74m) to EBITDA (213.4m): -0.03 < 3
Current Ratio: 0.04 > 1.5 & < 3
Outstanding Shares: last quarter (99.5m) vs 12m ago -2.38% < -2%
Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin)
Asset Turnover: 12.11% > 50% (prev 13.50%; Δ -1.39% > 0%)
Interest Coverage Ratio: 16.7k > 6 (EBIT TTM 213.4m / Interest Expense TTM 12.8k)
Altman Z'' 9.64
A: -0.09 (Total Current Assets 5.96m - Total Current Liabilities 161.7m) / Total Assets 1.76b
B: 0.18 (Retained Earnings 311.3m / Total Assets 1.76b)
C: 0.12 (EBIT TTM 213.4m / Avg Total Assets 1.79b)
D: 8.42 (Book Value of Equity 1.57b / Total Liabilities 186.8m)
Altman-Z'' = 9.64 = AAA
What is the price of ECAT shares?

As of September 25, 2026, the stock is trading at USD 14.08 with a total of 550,433 shares traded. Over the past week, the price has changed by -1.40%, over one month by -6.41%, over three months by -3.53% and over the past year by +6.88%.

Current recommended Stop Loss: 13.60 (which is 3.4% or 1.8 ATR below the current price).

Is ECAT a buy, sell or hold?

BlackRock ESG Capital has no consensus analysts rating.

BlackRock ESG Capital (ECAT) - Fundamental Data Overview as of 24 September 2026
Market Cap USD = 1.45b (1.45b USD * 1.0 USD.USD)
P/E Trailing = 5.7738
P/S = 5.7366
P/B = 0.9125
Revenue TTM = 216.2m USD
EBIT TTM = 213.4m USD
EBITDA TTM = 213.4m USD
 Long Term Debt = unknown (none)
 Short Term Debt = unknown (none)
 Debt = 168k USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -5.74m USD (calculated: Debt 168k - CCE 5.91m)
Enterprise Value = 1.44b USD (1.45b + Debt 168k - CCE 5.91m)
Interest Coverage Ratio = 16.7k (Ebit TTM 213.4m / Interest Expense TTM 12.8k)
EV/FCF = 4.18x (Enterprise Value 1.44b / FCF TTM 344.6m)
FCF Yield = 23.91% (FCF TTM 344.6m / Enterprise Value 1.44b)
 FCF Margin = 159.4% (FCF TTM 344.6m / Revenue TTM 216.2m)
 Net Margin = 98.68% (Net Income TTM 213.4m / Revenue TTM 216.2m)
 Gross Margin = unknown ((Revenue TTM 216.2m - Cost of Revenue TTM 12.8k) / Revenue TTM)
 Tobins Q-Ratio = 0.82 (Enterprise Value 1.44b / Total Assets 1.76b)
Interest Expense / Debt = 7.61% (Interest Expense 12.8k / Debt 168k)
Taxrate = 21.0% (US federal default 21%)
NOPAT = 168.6m (EBIT 213.4m * (1 - 21.00%))
Current Ratio = 0.04 (Total Current Assets 5.96m / Total Current Liabilities 161.7m)
Debt / Equity = 0.00 (Debt 168k / totalStockholderEquity, last quarter 1.57b)
Debt / EBITDA = -0.03 (Net Debt -5.74m / EBITDA 213.4m)
Debt / FCF = -0.02 (Net Debt -5.74m / FCF TTM 344.6m)
Total Stockholder Equity = 1.65b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.95% (Net Income 213.4m / Total Assets 1.76b)
RoE = 12.96% (Net Income TTM 213.4m / Total Stockholder Equity 1.65b)
RoCE = 13.35% (EBIT 213.4m / Capital Employed (Total Assets 1.76b - Current Liab 161.7m))
RoIC = 10.59% (NOPAT 168.6m / Invested Capital 1.59b)
WACC = 9.21% (E(1.45b)/V(1.45b) * Re(9.21%) + D(168k)/V(1.45b) * Rd(7.61%) * (1-Tc(0.21)))
Discount Rate = 9.21% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -93.93 | Cagr: -2.67%
[DCF] Terminal Value 72.74% ; FCFF base≈342.1m ; Y1≈348.8m ; Y5≈380.8m
[DCF] Fair Price = 51.82 (EV 5.15b - Net Debt -5.74m = Equity 5.15b / Shares 99.5m; r=9.21% [WACC]; 5y FCF grow 1.83% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: N/A | # QB: 0
Revenue Correlation: -99.15 | Revenue CAGR: -14.74% | SUE: N/A | # QB: 0